The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Swine Pseudorabies Vaccine Market Research Report 2025
Synopsis
Biological products for preventing pseudorabies in pigs
The global Swine Pseudorabies Vaccine market was valued at US$ 568 million in 2023 and is anticipated to reach US$ 752.1 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The growth and development of the swine industry, especially in regions with high pork consumption, has boosted the demand for porcine pseudorabies vaccine. As hog production expands to meet the growing demand for pork products, the need for effective disease prevention measures, including vaccination, becomes more important, which is driving the porcine pseudorabies vaccine market.
This report aims to provide a comprehensive presentation of the global market for Swine Pseudorabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Pseudorabies Vaccine.
Report Scope
The Swine Pseudorabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Box) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Pseudorabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Pseudorabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Keqian Biology
Zybio
Jinyu Biology
Cahic
Pulike Biology
Hayao
Qilu Animal Protection
Dahuanong
Huapai Biotechnology
Sinopharm Animal Health
Tecon
Zoetis
Boehringer Ingelheim
Bayer
Segment by Type
Swine Pseudorabies Vaccine , Live
Swine Pseudorabies Vaccine, Inactivated
Segment by Application
Farms
Individual
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Pseudorabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Pseudorabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Biological products for preventing pseudorabies in pigs
The global Swine Pseudorabies Vaccine market was valued at US$ 568 million in 2023 and is anticipated to reach US$ 752.1 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The growth and development of the swine industry, especially in regions with high pork consumption, has boosted the demand for porcine pseudorabies vaccine. As hog production expands to meet the growing demand for pork products, the need for effective disease prevention measures, including vaccination, becomes more important, which is driving the porcine pseudorabies vaccine market.
This report aims to provide a comprehensive presentation of the global market for Swine Pseudorabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Pseudorabies Vaccine.
Report Scope
The Swine Pseudorabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Box) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Pseudorabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Pseudorabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Keqian Biology
Zybio
Jinyu Biology
Cahic
Pulike Biology
Hayao
Qilu Animal Protection
Dahuanong
Huapai Biotechnology
Sinopharm Animal Health
Tecon
Zoetis
Boehringer Ingelheim
Bayer
Segment by Type
Swine Pseudorabies Vaccine , Live
Swine Pseudorabies Vaccine, Inactivated
Segment by Application
Farms
Individual
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Pseudorabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Pseudorabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Swine Pseudorabies Vaccine Market Overview
1.1 Product Overview and Scope of Swine Pseudorabies Vaccine
1.2 Swine Pseudorabies Vaccine Segment by Type
1.2.1 Global Swine Pseudorabies Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Swine Pseudorabies Vaccine , Live
1.2.3 Swine Pseudorabies Vaccine, Inactivated
1.3 Swine Pseudorabies Vaccine Segment by Application
1.3.1 Global Swine Pseudorabies Vaccine Market Value by Application: (2024-2030)
1.3.2 Farms
1.3.3 Individual
1.4 Global Swine Pseudorabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Swine Pseudorabies Vaccine Revenue 2019-2030
1.4.2 Global Swine Pseudorabies Vaccine Sales 2019-2030
1.4.3 Global Swine Pseudorabies Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Swine Pseudorabies Vaccine Market Competition by Manufacturers
2.1 Global Swine Pseudorabies Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Swine Pseudorabies Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Swine Pseudorabies Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Swine Pseudorabies Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Swine Pseudorabies Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Pseudorabies Vaccine, Product Type & Application
2.7 Swine Pseudorabies Vaccine Market Competitive Situation and Trends
2.7.1 Swine Pseudorabies Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Pseudorabies Vaccine Players Market Share by Revenue
2.7.3 Global Swine Pseudorabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Pseudorabies Vaccine Retrospective Market Scenario by Region
3.1 Global Swine Pseudorabies Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Swine Pseudorabies Vaccine Global Swine Pseudorabies Vaccine Sales by Region: 2019-2030
3.2.1 Global Swine Pseudorabies Vaccine Sales by Region: 2019-2024
3.2.2 Global Swine Pseudorabies Vaccine Sales by Region: 2025-2030
3.3 Global Swine Pseudorabies Vaccine Global Swine Pseudorabies Vaccine Revenue by Region: 2019-2030
3.3.1 Global Swine Pseudorabies Vaccine Revenue by Region: 2019-2024
3.3.2 Global Swine Pseudorabies Vaccine Revenue by Region: 2025-2030
3.4 North America Swine Pseudorabies Vaccine Market Facts & Figures by Country
3.4.1 North America Swine Pseudorabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Swine Pseudorabies Vaccine Sales by Country (2019-2030)
3.4.3 North America Swine Pseudorabies Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Swine Pseudorabies Vaccine Market Facts & Figures by Country
3.5.1 Europe Swine Pseudorabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Swine Pseudorabies Vaccine Sales by Country (2019-2030)
3.5.3 Europe Swine Pseudorabies Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Pseudorabies Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Pseudorabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Swine Pseudorabies Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Swine Pseudorabies Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Swine Pseudorabies Vaccine Market Facts & Figures by Country
3.7.1 Latin America Swine Pseudorabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Swine Pseudorabies Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Swine Pseudorabies Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Pseudorabies Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Pseudorabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Swine Pseudorabies Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Swine Pseudorabies Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Pseudorabies Vaccine Sales by Type (2019-2030)
4.1.1 Global Swine Pseudorabies Vaccine Sales by Type (2019-2024)
4.1.2 Global Swine Pseudorabies Vaccine Sales by Type (2025-2030)
4.1.3 Global Swine Pseudorabies Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Swine Pseudorabies Vaccine Revenue by Type (2019-2030)
4.2.1 Global Swine Pseudorabies Vaccine Revenue by Type (2019-2024)
4.2.2 Global Swine Pseudorabies Vaccine Revenue by Type (2025-2030)
4.2.3 Global Swine Pseudorabies Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Swine Pseudorabies Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Swine Pseudorabies Vaccine Sales by Application (2019-2030)
5.1.1 Global Swine Pseudorabies Vaccine Sales by Application (2019-2024)
5.1.2 Global Swine Pseudorabies Vaccine Sales by Application (2025-2030)
5.1.3 Global Swine Pseudorabies Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Swine Pseudorabies Vaccine Revenue by Application (2019-2030)
5.2.1 Global Swine Pseudorabies Vaccine Revenue by Application (2019-2024)
5.2.2 Global Swine Pseudorabies Vaccine Revenue by Application (2025-2030)
5.2.3 Global Swine Pseudorabies Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Swine Pseudorabies Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Keqian Biology
6.1.1 Keqian Biology Corporation Information
6.1.2 Keqian Biology Description and Business Overview
6.1.3 Keqian Biology Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Keqian Biology Swine Pseudorabies Vaccine Product Portfolio
6.1.5 Keqian Biology Recent Developments/Updates
6.2 Zybio
6.2.1 Zybio Corporation Information
6.2.2 Zybio Description and Business Overview
6.2.3 Zybio Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zybio Swine Pseudorabies Vaccine Product Portfolio
6.2.5 Zybio Recent Developments/Updates
6.3 Jinyu Biology
6.3.1 Jinyu Biology Corporation Information
6.3.2 Jinyu Biology Description and Business Overview
6.3.3 Jinyu Biology Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jinyu Biology Swine Pseudorabies Vaccine Product Portfolio
6.3.5 Jinyu Biology Recent Developments/Updates
6.4 Cahic
6.4.1 Cahic Corporation Information
6.4.2 Cahic Description and Business Overview
6.4.3 Cahic Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cahic Swine Pseudorabies Vaccine Product Portfolio
6.4.5 Cahic Recent Developments/Updates
6.5 Pulike Biology
6.5.1 Pulike Biology Corporation Information
6.5.2 Pulike Biology Description and Business Overview
6.5.3 Pulike Biology Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pulike Biology Swine Pseudorabies Vaccine Product Portfolio
6.5.5 Pulike Biology Recent Developments/Updates
6.6 Hayao
6.6.1 Hayao Corporation Information
6.6.2 Hayao Description and Business Overview
6.6.3 Hayao Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hayao Swine Pseudorabies Vaccine Product Portfolio
6.6.5 Hayao Recent Developments/Updates
6.7 Qilu Animal Protection
6.6.1 Qilu Animal Protection Corporation Information
6.6.2 Qilu Animal Protection Description and Business Overview
6.6.3 Qilu Animal Protection Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qilu Animal Protection Swine Pseudorabies Vaccine Product Portfolio
6.7.5 Qilu Animal Protection Recent Developments/Updates
6.8 Dahuanong
6.8.1 Dahuanong Corporation Information
6.8.2 Dahuanong Description and Business Overview
6.8.3 Dahuanong Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Dahuanong Swine Pseudorabies Vaccine Product Portfolio
6.8.5 Dahuanong Recent Developments/Updates
6.9 Huapai Biotechnology
6.9.1 Huapai Biotechnology Corporation Information
6.9.2 Huapai Biotechnology Description and Business Overview
6.9.3 Huapai Biotechnology Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Huapai Biotechnology Swine Pseudorabies Vaccine Product Portfolio
6.9.5 Huapai Biotechnology Recent Developments/Updates
6.10 Sinopharm Animal Health
6.10.1 Sinopharm Animal Health Corporation Information
6.10.2 Sinopharm Animal Health Description and Business Overview
6.10.3 Sinopharm Animal Health Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sinopharm Animal Health Swine Pseudorabies Vaccine Product Portfolio
6.10.5 Sinopharm Animal Health Recent Developments/Updates
6.11 Tecon
6.11.1 Tecon Corporation Information
6.11.2 Tecon Swine Pseudorabies Vaccine Description and Business Overview
6.11.3 Tecon Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tecon Swine Pseudorabies Vaccine Product Portfolio
6.11.5 Tecon Recent Developments/Updates
6.12 Zoetis
6.12.1 Zoetis Corporation Information
6.12.2 Zoetis Swine Pseudorabies Vaccine Description and Business Overview
6.12.3 Zoetis Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zoetis Swine Pseudorabies Vaccine Product Portfolio
6.12.5 Zoetis Recent Developments/Updates
6.13 Boehringer Ingelheim
6.13.1 Boehringer Ingelheim Corporation Information
6.13.2 Boehringer Ingelheim Swine Pseudorabies Vaccine Description and Business Overview
6.13.3 Boehringer Ingelheim Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Boehringer Ingelheim Swine Pseudorabies Vaccine Product Portfolio
6.13.5 Boehringer Ingelheim Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Corporation Information
6.14.2 Bayer Swine Pseudorabies Vaccine Description and Business Overview
6.14.3 Bayer Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bayer Swine Pseudorabies Vaccine Product Portfolio
6.14.5 Bayer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Pseudorabies Vaccine Industry Chain Analysis
7.2 Swine Pseudorabies Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Pseudorabies Vaccine Production Mode & Process
7.4 Swine Pseudorabies Vaccine Sales and Marketing
7.4.1 Swine Pseudorabies Vaccine Sales Channels
7.4.2 Swine Pseudorabies Vaccine Distributors
7.5 Swine Pseudorabies Vaccine Customers
8 Swine Pseudorabies Vaccine Market Dynamics
8.1 Swine Pseudorabies Vaccine Industry Trends
8.2 Swine Pseudorabies Vaccine Market Drivers
8.3 Swine Pseudorabies Vaccine Market Challenges
8.4 Swine Pseudorabies Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Swine Pseudorabies Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Swine Pseudorabies Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Swine Pseudorabies Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Swine Pseudorabies Vaccine Sales (Box) of Key Manufacturers (2019-2024)
Table 5. Global Swine Pseudorabies Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Swine Pseudorabies Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Swine Pseudorabies Vaccine Average Price (US$/Box) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Swine Pseudorabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Swine Pseudorabies Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Swine Pseudorabies Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Swine Pseudorabies Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Pseudorabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Pseudorabies Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Pseudorabies Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Swine Pseudorabies Vaccine Sales by Region (2019-2024) & (Box)
Table 18. Global Swine Pseudorabies Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Swine Pseudorabies Vaccine Sales by Region (2025-2030) & (Box)
Table 20. Global Swine Pseudorabies Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Swine Pseudorabies Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Swine Pseudorabies Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Swine Pseudorabies Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Swine Pseudorabies Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Swine Pseudorabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Swine Pseudorabies Vaccine Sales by Country (2019-2024) & (Box)
Table 27. North America Swine Pseudorabies Vaccine Sales by Country (2025-2030) & (Box)
Table 28. North America Swine Pseudorabies Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Swine Pseudorabies Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Swine Pseudorabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Swine Pseudorabies Vaccine Sales by Country (2019-2024) & (Box)
Table 32. Europe Swine Pseudorabies Vaccine Sales by Country (2025-2030) & (Box)
Table 33. Europe Swine Pseudorabies Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Swine Pseudorabies Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Swine Pseudorabies Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Swine Pseudorabies Vaccine Sales by Region (2019-2024) & (Box)
Table 37. Asia Pacific Swine Pseudorabies Vaccine Sales by Region (2025-2030) & (Box)
Table 38. Asia Pacific Swine Pseudorabies Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Swine Pseudorabies Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Swine Pseudorabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Swine Pseudorabies Vaccine Sales by Country (2019-2024) & (Box)
Table 42. Latin America Swine Pseudorabies Vaccine Sales by Country (2025-2030) & (Box)
Table 43. Latin America Swine Pseudorabies Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Swine Pseudorabies Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Swine Pseudorabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Swine Pseudorabies Vaccine Sales by Country (2019-2024) & (Box)
Table 47. Middle East & Africa Swine Pseudorabies Vaccine Sales by Country (2025-2030) & (Box)
Table 48. Middle East & Africa Swine Pseudorabies Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Swine Pseudorabies Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Swine Pseudorabies Vaccine Sales (Box) by Type (2019-2024)
Table 51. Global Swine Pseudorabies Vaccine Sales (Box) by Type (2025-2030)
Table 52. Global Swine Pseudorabies Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Swine Pseudorabies Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Swine Pseudorabies Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Swine Pseudorabies Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Swine Pseudorabies Vaccine Price (US$/Box) by Type (2019-2024)
Table 59. Global Swine Pseudorabies Vaccine Price (US$/Box) by Type (2025-2030)
Table 60. Global Swine Pseudorabies Vaccine Sales (Box) by Application (2019-2024)
Table 61. Global Swine Pseudorabies Vaccine Sales (Box) by Application (2025-2030)
Table 62. Global Swine Pseudorabies Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Swine Pseudorabies Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Swine Pseudorabies Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Swine Pseudorabies Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Swine Pseudorabies Vaccine Price (US$/Box) by Application (2019-2024)
Table 69. Global Swine Pseudorabies Vaccine Price (US$/Box) by Application (2025-2030)
Table 70. Keqian Biology Corporation Information
Table 71. Keqian Biology Description and Business Overview
Table 72. Keqian Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 73. Keqian Biology Swine Pseudorabies Vaccine Product
Table 74. Keqian Biology Recent Developments/Updates
Table 75. Zybio Corporation Information
Table 76. Zybio Description and Business Overview
Table 77. Zybio Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 78. Zybio Swine Pseudorabies Vaccine Product
Table 79. Zybio Recent Developments/Updates
Table 80. Jinyu Biology Corporation Information
Table 81. Jinyu Biology Description and Business Overview
Table 82. Jinyu Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 83. Jinyu Biology Swine Pseudorabies Vaccine Product
Table 84. Jinyu Biology Recent Developments/Updates
Table 85. Cahic Corporation Information
Table 86. Cahic Description and Business Overview
Table 87. Cahic Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 88. Cahic Swine Pseudorabies Vaccine Product
Table 89. Cahic Recent Developments/Updates
Table 90. Pulike Biology Corporation Information
Table 91. Pulike Biology Description and Business Overview
Table 92. Pulike Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 93. Pulike Biology Swine Pseudorabies Vaccine Product
Table 94. Pulike Biology Recent Developments/Updates
Table 95. Hayao Corporation Information
Table 96. Hayao Description and Business Overview
Table 97. Hayao Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 98. Hayao Swine Pseudorabies Vaccine Product
Table 99. Hayao Recent Developments/Updates
Table 100. Qilu Animal Protection Corporation Information
Table 101. Qilu Animal Protection Description and Business Overview
Table 102. Qilu Animal Protection Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 103. Qilu Animal Protection Swine Pseudorabies Vaccine Product
Table 104. Qilu Animal Protection Recent Developments/Updates
Table 105. Dahuanong Corporation Information
Table 106. Dahuanong Description and Business Overview
Table 107. Dahuanong Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 108. Dahuanong Swine Pseudorabies Vaccine Product
Table 109. Dahuanong Recent Developments/Updates
Table 110. Huapai Biotechnology Corporation Information
Table 111. Huapai Biotechnology Description and Business Overview
Table 112. Huapai Biotechnology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 113. Huapai Biotechnology Swine Pseudorabies Vaccine Product
Table 114. Huapai Biotechnology Recent Developments/Updates
Table 115. Sinopharm Animal Health Corporation Information
Table 116. Sinopharm Animal Health Description and Business Overview
Table 117. Sinopharm Animal Health Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 118. Sinopharm Animal Health Swine Pseudorabies Vaccine Product
Table 119. Sinopharm Animal Health Recent Developments/Updates
Table 120. Tecon Corporation Information
Table 121. Tecon Description and Business Overview
Table 122. Tecon Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 123. Tecon Swine Pseudorabies Vaccine Product
Table 124. Tecon Recent Developments/Updates
Table 125. Zoetis Corporation Information
Table 126. Zoetis Description and Business Overview
Table 127. Zoetis Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 128. Zoetis Swine Pseudorabies Vaccine Product
Table 129. Zoetis Recent Developments/Updates
Table 130. Boehringer Ingelheim Corporation Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 133. Boehringer Ingelheim Swine Pseudorabies Vaccine Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. Bayer Corporation Information
Table 136. Bayer Description and Business Overview
Table 137. Bayer Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2019-2024)
Table 138. Bayer Swine Pseudorabies Vaccine Product
Table 139. Bayer Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Swine Pseudorabies Vaccine Distributors List
Table 143. Swine Pseudorabies Vaccine Customers List
Table 144. Swine Pseudorabies Vaccine Market Trends
Table 145. Swine Pseudorabies Vaccine Market Drivers
Table 146. Swine Pseudorabies Vaccine Market Challenges
Table 147. Swine Pseudorabies Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Swine Pseudorabies Vaccine
Figure 2. Global Swine Pseudorabies Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Swine Pseudorabies Vaccine Market Share by Type in 2023 & 2030
Figure 4. Swine Pseudorabies Vaccine , Live Product Picture
Figure 5. Swine Pseudorabies Vaccine, Inactivated Product Picture
Figure 6. Global Swine Pseudorabies Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Swine Pseudorabies Vaccine Market Share by Application in 2023 & 2030
Figure 8. Farms
Figure 9. Individual
Figure 10. Global Swine Pseudorabies Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Swine Pseudorabies Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Swine Pseudorabies Vaccine Sales (2019-2030) & (Box)
Figure 13. Global Swine Pseudorabies Vaccine Average Price (US$/Box) & (2019-2030)
Figure 14. Swine Pseudorabies Vaccine Report Years Considered
Figure 15. Swine Pseudorabies Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Swine Pseudorabies Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Swine Pseudorabies Vaccine Players: Market Share by Revenue in 2023
Figure 18. Swine Pseudorabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Swine Pseudorabies Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Swine Pseudorabies Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Swine Pseudorabies Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Swine Pseudorabies Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Swine Pseudorabies Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Swine Pseudorabies Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Swine Pseudorabies Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Swine Pseudorabies Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Latin America Swine Pseudorabies Vaccine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Swine Pseudorabies Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Swine Pseudorabies Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Swine Pseudorabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Swine Pseudorabies Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Swine Pseudorabies Vaccine by Type (2019-2030)
Figure 54. Global Swine Pseudorabies Vaccine Price (US$/Box) by Type (2019-2030)
Figure 55. Global Sales Market Share of Swine Pseudorabies Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Swine Pseudorabies Vaccine by Application (2019-2030)
Figure 57. Global Swine Pseudorabies Vaccine Price (US$/Box) by Application (2019-2030)
Figure 58. Swine Pseudorabies Vaccine Value Chain
Figure 59. Swine Pseudorabies Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
